Asia Pacific Departmental Pacs Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 3.19 Billion |
 Market Size (Forecast Year) |
USD 5.19 Billion |
 CAGR |
% |
| Major Markets Players |
|
>部门 PACS 市场，按产品类型（传统 PACS、专业 PACS）、组件（软件、服务、硬件）、应用（MRI、计算机断层扫描、数字放射摄影、超声波、核成像、 C 臂等）、集成级别（集成 PACS、独立 PACS）、最终用户（医院、放射科连锁店/中心、门诊手术中心等）、分销渠道（直接招标、第三方管理员等）划分 - 行业趋势和预测到 2031 年。
亚太地区部门级 PACS 市场分析与洞察
部门 PACS 市场涵盖医疗信息技术领域的一部分，专门用于存储、检索、管理和分发特定医院部门或医学专科内的医学影像数据。PACS 是现代医学影像工作流程不可或缺的一部分，它使放射科医生、心脏病专家、肿瘤科医生和其他专家能够以数字方式存储和访问诊断图像，例如 X 光片、MRI、CT 扫描和超声波。该系统取代了传统的基于胶片的成像，提高了图像数据的效率、准确性和可访问性，从而增强了患者护理。部门 PACS 是为满足各个部门的独特需求和工作流程而量身定制的，通常具有专门的工具和界面，可简化特定医疗实践的成像过程。这些系统有助于与其他医院信息系统 (HIS) 和电子健康记录 (EHR) 无缝集成，确保在整个护理过程中随时可用患者影像数据。部门 PACS 市场受到医学影像程序数量的增加、影像技术的进步、对提高诊断准确性的需求以及医疗保健数字化的推动。此外，监管要求和降低医疗成本的重点进一步推动了 PACS 在部门环境中的采用。随着医疗保健提供商继续认识到高效图像数据管理和改善患者治疗效果的价值，部门 PACS 市场有望实现大幅增长。
Data Bridge Market Research 分析称，部门 PACS 市场规模预计将从 2023 年的 31.9 亿美元增至 2031 年的 51.9 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 6.3%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制为 2016 – 2021） |
|
定量单位 |
收入（十亿美元） |
|
涵盖的领域 |
产品类型（传统 PACS、专业 PACS）、组件（软件、服务、硬件）、应用（磁共振成像 (MRI)、计算机断层扫描 (CT)、数字射线照相、超声波、核成像、C 臂、其他）、集成级别（集成 PACS、独立 PACS）、最终用户（医院、放射科连锁店/中心、门诊手术中心、其他）、分销渠道（直接投标、第三方管理员等） |
|
覆盖国家 |
中国、日本、印度、韩国、澳大利亚、台湾、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、新西兰、越南、亚太地区其他地区 |
|
涵盖的市场参与者 |
富士胶片株式会社、通用电气医疗集团、荷兰皇家飞利浦公司、爱克发-吉华集团、Hyland Software Inc.、利盟国际公司、Mach 7 Technologies Limited、Novarad Enterprise Healthcare Solutions、Reyence、西门子（Siemens Healthcare Private Limited）、Sectra AB、Softneta、SinoVision、TeleRAD Reporting Services Private Limited 和 Voyager Imaging 等 |
市场定义
部门 PACS 市场涵盖医疗信息技术领域的一部分，专门用于存储、检索、管理和分发特定医院部门或医学专科内的医学影像数据。PACS 是现代医学影像工作流程不可或缺的一部分，它使放射科医生、心脏病专家、肿瘤科医生和其他专家能够以数字方式存储和访问诊断图像，例如 X 光片、MRI、CT 扫描和超声波。该系统取代了传统的基于胶片的成像，提高了图像数据的效率、准确性和可访问性，从而增强了患者护理。部门 PACS 是为满足各个部门的独特需求和工作流程而量身定制的，通常具有专门的工具和界面，可简化特定医疗实践的成像过程。这些系统有助于与其他医院信息系统 (HIS) 和电子健康记录 (EHR) 无缝集成，确保在整个护理过程中随时可用患者影像数据。部门 PACS 市场受到医学影像程序数量的增加、影像技术的进步、对提高诊断准确性的需求以及医疗保健数字化的推动。此外，监管要求和降低医疗成本的重点进一步推动了 PACS 在部门环境中的采用。随着医疗保健提供商继续认识到高效图像数据管理和改善患者治疗效果的价值，部门 PACS 市场有望实现大幅增长。
部门 PACS 市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
司机
- 早期疾病检测需求不断增长
对早期疾病检测的需求不断增长，极大地推动了亚太地区部门 PACS（图片存档和通信系统）市场的发展，主要是因为 PACS 技术提高了诊断过程的效率和准确性。早期疾病检测通常依赖于先进的成像技术，这些技术会产生大量需要高效存储、检索和分析的数据。PACS 系统提供了一种数字解决方案来管理这些数据，允许快速轻松地访问医学图像和相关信息。这种能力对于早期疾病检测至关重要，及时准确的诊断可以大大改善患者的治疗效果。此外，亚太地区对预防性医疗措施的认识和采用日益提高，导致对医疗基础设施（包括成像技术和 PACS 系统）的投资增加。政府和医疗保健组织正在优先考虑早期检测计划，以减轻慢性病的长期负担，这进一步推动了对强大 PACS 解决方案的需求。人工智能 (AI) 和机器学习 (ML) 与 PACS 的集成也加速了这一趋势，因为这些技术增强了图像分析、提高了诊断准确性并促进了疾病的早期识别。因此，随着医疗保健提供商努力采用创新解决方案来满足对高效和有效诊断工具日益增长的需求，对早期疾病检测的日益重视正在推动亚太地区部门 PACS 市场的扩张。
例如，
- 2023 年 11 月，根据《放射肿瘤系统》杂志发表的一篇文章，PACS 探讨了诊断成像设备在早期识别疾病方面的关键作用。X 射线、CT 扫描、PET 扫描、MRI 和超声波等诊断成像技术仍然是抵御隐藏健康威胁的第一线防御者。它们使医疗保健专业人员能够窥视身体内部，发现异常，通常在症状出现之前。在最近的一项研究中，发现通过诊断成像进行早期诊断可使肺癌癌症治疗方案的有效性提高约 20%（美国癌症研究协会）。PACS 在疾病的预防和治疗中起着至关重要的作用
- 2022 年 11 月，根据 GE HealthCare 发表的一篇文章，当患者无法充分发挥其健康潜力时，健康不平等体现在寿命、生活质量、发病率、残疾率和死亡率、疾病严重程度以及获得治疗的机会等方面的差异。无法获得医疗路径中的重要组件（例如医学影像）会对健康结果产生巨大影响。需要像 PACS 这样的先进医学影像系统来专注于非传染性或慢性疾病的早期诊断，例如心血管疾病、慢性呼吸系统疾病和糖尿病。早期诊断对于避免进一步患病和错误治疗以及费用支出是必要的。
- 2020 年 8 月，根据 EIT Health 发布的一份报告，PACS 等新型医疗技术不断快速发展，使人们能够在早期发现和诊断疾病。这一趋势也称为早期诊断，预计将导致医疗保健系统发生重大变化，因为疾病的发现和治疗方式将被重塑。它有可能提高护理质量、降低成本并在早期提供治疗。降低付款人和社会的下游治疗成本，降低住院率和医院和临床医生的压力，为患者开出正确的治疗方案，避免不必要的干预
对早期疾病检测的日益关注是亚太地区部门级 PACS 市场的重要驱动力，因为 PACS 技术简化了海量影像数据的管理，而这对于及时准确的诊断至关重要。随着预防性医疗保健在该地区的发展，对 PACS 系统的投资也在增加，而人工智能和机器学习的集成则提高了诊断的准确性。这一趋势凸显了 PACS 在满足对有效诊断工具日益增长的需求方面发挥的关键作用，从而促进了市场增长。
克制
- 实施医学影像管理成本高昂
实施医疗影像管理系统（如 PACS（图片存档和通信系统））的高成本是亚太地区部门级 PACS 市场发展的一个重大制约因素。这些成本不仅包括对复杂硬件和软件的初始投资，还包括与系统维护、升级和医务人员培训相关的持续费用。亚太地区规模较小的医疗机构和发展中地区的医疗机构通常面临预算限制，因此很难为这些先进的影像管理解决方案分配足够的资金。此外，将 PACS 与现有医院信息系统集成并确保数据安全和遵守医疗法规的财务负担也增加了总成本。这些经济挑战可能会阻止医疗保健提供商采用 PACS 技术，尽管该技术在提高诊断准确性和运营效率方面具有优势。因此，亚太地区 PACS 市场的增长可能会受到阻碍，特别是在较不富裕的地区，高昂的实施和维护成本是采用的重大障碍。
例如，
- 2024 年 4 月，根据全球最大的 IT 服务提供商之一 Appinventiv 的一篇文章，开发 PACS 和 DICOM 医学成像软件的平均成本从 30,000 美元到 300,000 美元不等。该成本受到软件复杂性、交付时间表、受聘软件开发公司的位置、遵守 HIPAA 等监管标准以及开发团队所需的专业知识水平等因素的影响。这起到了限制作用，阻碍了市场的增长
- 2019 年 11 月，PACS 代表着一项重大投资，因为它是一个单独的软件应用程序，必须独立于现有的供应商中立档案 (VNA) 和 DICOM 查看器购买。在最近的发展中，PACS 的成本很高，这成为医疗设备市场的重大制约因素。此外，将 VNA 集成到现有的 PACS 设置中可能会产生大量额外费用，进一步增加财务负担并阻碍市场的增长
实施医疗成像管理系统（包括 PACS）的高成本是亚太地区部门级 PACS 市场发展的一大制约因素。这些费用包括初始投资、持续维护、系统升级和员工培训，对于规模较小或预算有限的医疗机构来说，可能难以承受。将 PACS 与现有系统集成并确保法规合规的财务负担进一步加剧了这一挑战。因此，这些高成本可能会限制 PACS 技术的采用，尤其是在较不富裕的地区，并阻碍市场增长。
机会
- 人工智能技术在成像领域的应用
人工智能技术在成像领域的应用为亚太地区部门 PACS（图片存档和通信系统）市场带来了重大机遇，因为它可以提高诊断准确性、效率和工作流程自动化。人工智能算法可以高精度地分析医学图像，帮助放射科医生更有效地检测异常、诊断病情和优先处理紧急情况。这种集成简化了成像过程，减少了图像分析和解释所需的时间，这在高容量环境中至关重要。人工智能通过启用自动图像分割、预测分析和决策支持工具等高级功能来增强 PACS 系统的功能，从而改善整体临床结果。随着亚太地区的医疗保健提供者越来越多地寻求利用人工智能来管理不断增长的医学图像量并优化诊断工作流程，对采用这些先进技术的 PACS 系统的需求预计将上升。这种转变不仅将 PACS 系统定位为现代医疗保健基础设施不可或缺的组成部分，而且为亚太地区的创新和市场增长开辟了新的途径。
例如，
- 2024 年 6 月，据 MIT 新闻报道，人工智能和 PACS 经常在医疗诊断中发挥作用，尤其是在分析 X 光片等图像时。这些模型还被证明具有一些令人惊讶的能力。2022 年，麻省理工学院的研究人员报告称，人工智能模型有望根据患者的胸部 X 光片准确预测其种族。他们的研究团队现在发现，最准确的人口预测模型
- 2024 年 6 月，据 MIT 新闻报道，截至 2024 年 5 月，FDA 已批准 882 种支持 AI 的医疗设备，其中 671 种设计用于放射学。自 2022 年 Ghassemi 和她的同事证明这些诊断模型可以准确预测种族以来，他们和其他研究人员已经证明，此类模型在预测性别和年龄方面也非常出色，即使这些模型没有接受过这些任务的训练
- 2024 年 3 月，根据 Elsevier 发表的一篇文章，重点介绍了增强图像分析、运营效率、预测和个性化医疗以及诊断成像中的临床决策支持等 AI 领域。结论是，AI 正在通过提高准确性、效率和个性化医疗服务来彻底改变诊断成像
- 2024 年 4 月，根据爱思唯尔发表的一篇文章，旨在绘制可用的技术工具，以改善初级卫生保健中影像的可及性；确定促进因素和障碍，以及广泛采用技术解决方案的知识差距。建议远程放射学与人工智能和移动数字成像单元相结合，可以解决放射科医生短缺的问题；加强针对人口筛查和紧急护理的计划
人工智能技术在成像领域的应用为亚太地区部门 PACS 市场创造了巨大的机会，提高了诊断准确性和工作流程效率。人工智能实现了自动图像分析和预测分析等高级功能，从而简化了成像过程并改善了临床结果。随着亚太地区的医疗保健提供商越来越多地整合人工智能来应对日益增长的成像需求，对先进 PACS 系统的需求预计将上升，从而推动市场增长和创新。
挑战
- 技术复杂性导致的数据安全和隐私问题
图像存档和通信系统 (PACS) 是一项复杂的技术，需要高级 IT 专业知识来进行安装、配置和维护。与这些系统相关的技术要求可能导致巨大的运营成本和资源分配挑战。确保系统可靠性和最大限度地减少停机时间至关重要，因为系统故障、数据丢失或软件故障等中断可能会延迟访问关键医学图像，进而影响诊断准确性和治疗及时性。故障排除和持续系统更新需要专门的 IT 支持，这进一步复杂化并增加了维护这些系统的成本。
例如，
- 2020 年 12 月，根据 NIST 发表的一篇文章，由于医疗保健组织 (HDO) 内不同部门的医学成像需求各不相同，并且使用多个 PACS 或归档系统，因此确保 PACS 的安全十分困难。此外，还涉及外部成像专家，不同的临床用户从不同位置访问 PACS，这造成了复杂的环境，增加了网络安全风险
- 这种复杂性对亚太地区部门级 PACS 市场构成了挑战，因为它很难在分散且广泛访问的 PACS 生态系统中确保强大的网络安全措施
- 根据 Open MedScience 发表的一篇文章，PACS 系统依赖于复杂的技术，这可能导致系统故障、数据丢失和软件故障等问题，从而导致停机和患者护理延迟。此外，PACS 需要对放射科工作人员进行专门且通常昂贵的培训，并且需要不断更新以跟上技术进步的步伐。这一挑战影响了亚太地区部门 PACS 市场，因为它增加了运营成本，并可能因技术问题和持续的员工培训需求而中断患者护理
技术复杂性加剧了人们对数据安全和隐私的担忧，因为管理和保护跨多样化和复杂系统的敏感医疗信息尤其具有挑战性，从而影响医疗设施的整体效率和安全性。
最新动态
- 2024 年 1 月，FUJIFILM Diosynth Biotechnologies 与 SHL Medical 达成战略合作协议，以帮助满足市场对自动注射器药物日益增长的需求。此次合作是 SHL 联盟管理计划的一部分，旨在简化流程并提高制药和生物技术公司的效率，这些公司主要通过 SHL 的旗舰平台 Molly 提供自动注射器成品服务
- 2022 年 8 月，爱克发-吉华集团与 AURELIUS 集团签署了一项股份购买协议，在其正在进行的转型过程中出售其胶印解决方案部门。此次出售使该集团能够更加专注于其增长业务
部门 PACS 市场范围
部门级 PACS 市场根据产品类型、组件、应用、集成级别、最终用户、分销渠道分为六个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
按产品类型（传统 PACS、专业 PACS）、组件（软件、服务、硬件）、应用（磁共振成像 (MRI)、计算机断层扫描 (CT)、数字射线照相、超声波、核成像、C 臂、其他）、集成级别（集成 PACS、独立 PACS）、最终用户（医院、放射科连锁店/中心、门诊手术中心、其他）、分销渠道（直接投标、第三方管理员、其他）
产品类型
- 传统 PACS
- 专业 PACS
根据产品类型，市场分为传统 PACS 和专业 PACS。
成分
- 软件
- 服务
- 硬件
根据组件，市场分为软件、服务和硬件。
应用
- 磁共振成像（MRI）
- 计算机断层扫描 (CT)
- 数字射线照相术
- 超声波
- 核成像
- C 型臂
- 其他的
根据应用，市场分为磁共振成像 (MRI)、计算机断层扫描 (CT)、数字射线成像、超声波、核成像、 C 臂等。
集成级别
- 集成 PACS
- 独立 PACS
根据集成程度，市场分为集成 PACS 和独立 PACS 。
最终用户
- 医院
- 放射科连锁机构/中心，
- 门诊手术中心
- 其他的
根据最终用户，市场分为医院、放射科连锁店/中心、门诊手术中心和其他。
分销渠道
- 直接招标
- 第三方管理员
- 其他的
根据分销渠道，市场细分为直接招标、第三方管理者和其他。
部门 PACS 市场区域分析/见解
部门 PACS 市场根据产品类型、组件、应用、集成级别、最终用户和分销渠道分为九个显著的部分。
本市场报告涵盖的国家包括中国、日本、印度、韩国、澳大利亚、台湾、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、新西兰、越南和亚太地区其他地区。
日本在亚太地区部门 PACS 市场中正在不断增长，并且随着该国慢性病患病率的不断上升，预计将占据市场主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战以及销售渠道的影响。
竞争格局和亚太地区部门 PACS 市场份额分析
部门 PACS 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司市场概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。
一些主要的市场参与者包括富士胶片株式会社、通用电气医疗集团、荷兰皇家飞利浦公司、爱克发吉华集团、Hyland Software Inc.、利盟国际公司、Mach 7 Technologies Limited、Novarad Enterprise Healthcare Solutions、Reyence、西门子（Siemens Healthcare Private Limited）、Sectra AB、Softneta、SinoVision、TeleRAD Reporting Services Private Limited 和 Voyager Imaging 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR EARLY DISEASE DETECTION
6.1.2 INCREASING IMAGING EQUIPMENT USAGE
6.1.3 THE PREVALENCE OF CHRONIC DISEASE AND PAIN-RELATED CONDITIONS
6.1.4 RISE IN BONE INJURIES AND ORTHOPEDIC CONDITIONS AND ITS IMAGING
6.2 RESTRAINTS
6.2.1 HIGH COSTS ASSOCIATED WITH THE IMPLEMENTATION OF MEDICAL IMAGING MANAGEMENT
6.2.2 STRINGENT REGULATORY REQUIREMENTS INVOLVED IN THE MANAGEMENT PROCESS
6.3 OPPORTUNITIES
6.3.1 ADOPTION OF AI TECHNOLOGY IN IMAGING
6.3.2 IMPROVEMENT IN GOVERNMENTAL STANDARDS AND POLICIES
6.3.3 ADVANCEMENTS IN RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 DATA SECURITY AND PRIVACY CONCERNS DUE TO TECHNICAL COMPLEXITY
6.4.2 INCREASING IN THE INTEROPERABILITY ISSUES
7 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 TRADITIONAL PACS
7.2.1 IMAGE PROCESSING
7.2.2 IMAGE MANAGEMENT
7.3 SPECIALITY PACS
7.3.1 CARDIOLOGY PACS
7.3.2 ONCOLOGY PACS
7.3.3 PATHOLOGY PACS
7.3.4 ORTHOPEDIC PACS
7.3.5 DERMATOLOGY PACS
7.3.6 OPTHALMOLOGY PACS
7.3.7 DENTAL PACS
7.3.8 VETERINARY PACS
7.3.9 OTHERS
8 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT
8.1 OVERVIEW
8.2 SOFTWARE
8.2.1 WEB/ CLOUD BASED
8.2.2 ON PREMISES
8.2.3 HYBRID
8.3 SERVICES
8.4 HARDWARE
9 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 MAGNETIC RESONANCE IMAGING (MRI)
9.3 COMPUTED TOMOGRAPHY (CT)
9.4 DIGITAL RADIOGRAPHY
9.5 ULTRASOUND
9.6 NUCLEAR IMAGING
9.7 C-ARMS
9.8 OTHERS
10 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL
10.1 OVERVIEW
10.2 INTEGRATED PACS
10.3 STANDALONE PACS
11 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 LARGE HOSPITALS
11.2.1.2 MEDIUM-SIZED HOSPITALS
11.2.1.3 SMALL HOSPITALS
11.3 RADIOLOGY CHAINS/ CENTERS
11.4 AMBULATORY SURGERY CENTERS
11.5 OTHERS
12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDERS
12.3 THIRD PARTY ADMINISTRATORS
12.4 OTHERS
13 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY
13.1 ASIA-PACIFIC
13.1.1 JAPAN
13.1.2 CHINA
13.1.3 AUSTRALIA
13.1.4 INDIA
13.1.5 SOUTH KOREA
13.1.6 SINGAPORE
13.1.7 MALAYSIA
13.1.8 THAILAND
13.1.9 INDONESIA
13.1.10 VIETNAM
13.1.11 PHILIPPINES
13.1.12 REST OF ASIA-PACIFIC
14 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 FUJIFILM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 GE HEALTHCARE
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 KONINKLIJKE PHILIPS N.V.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 AGFA-GEVAERT GROUP.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENTS
16.5 HYLAND SOFTWARE, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 PRODUCT PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 LEXMARK INTERNATIONAL, INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 MACH 7 TECHNOLOGIES LIMITED
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 NOVARAD ENTERPRISE HEALTHCARE SOLUTIONS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 RAYENCE
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 SIEMENS (SIEMENS HEALTHCARE PRIVATE LIMITED)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 SECTRA AB
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 SOFTNETA
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 SINOVISION
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 TELERAD REPORTING SERVICES PRIVATE LIMITED
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 VOYAGER IMAGING
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC (APAC) IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC (APAC) SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC (APAC) CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC (APAC) ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC (APAC) ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC (APAC) DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC (APAC) OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC (APAC) VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC (APAC) TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 20 JAPAN DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 21 JAPAN TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 22 JAPAN IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 JAPAN SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 JAPAN CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 25 JAPAN ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 26 JAPAN ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 27 JAPAN DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 28 JAPAN OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 29 JAPAN DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 30 JAPAN VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 31 JAPAN DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 32 JAPAN SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 33 JAPAN DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 JAPAN DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 35 JAPAN DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 36 JAPAN HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 JAPAN DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 38 CHINA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 CHINA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 40 CHINA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 CHINA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 CHINA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 43 CHINA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 44 CHINA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 45 CHINA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 46 CHINA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 47 CHINA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 48 CHINA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 49 CHINA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 50 CHINA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 51 CHINA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 52 CHINA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 53 CHINA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 54 CHINA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 CHINA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 56 AUSTRALIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 AUSTRALIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 58 AUSTRALIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 AUSTRALIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 AUSTRALIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 61 AUSTRALIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 62 AUSTRALIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 63 AUSTRALIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 64 AUSTRALIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 65 AUSTRALIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 66 AUSTRALIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 67 AUSTRALIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 68 AUSTRALIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 AUSTRALIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 70 AUSTRALIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 71 AUSTRALIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 72 AUSTRALIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 AUSTRALIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 74 INDIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 INDIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 76 INDIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 INDIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 INDIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 79 INDIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 80 INDIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 81 INDIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 82 INDIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 83 INDIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 84 INDIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 85 INDIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 86 INDIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 INDIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 88 INDIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 89 INDIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 90 INDIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 91 INDIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 92 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 SOUTH KOREA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 94 SOUTH KOREA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 SOUTH KOREA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 SOUTH KOREA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 97 SOUTH KOREA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 98 SOUTH KOREA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 99 SOUTH KOREA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 100 SOUTH KOREA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 101 SOUTH KOREA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 102 SOUTH KOREA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 103 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 104 SOUTH KOREA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 106 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 107 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 108 SOUTH KOREA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 SOUTH KOREA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 110 SINGAPORE DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 SINGAPORE TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 112 SINGAPORE IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 SINGAPORE SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 SINGAPORE CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 115 SINGAPORE ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 116 SINGAPORE ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 117 SINGAPORE DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 118 SINGAPORE OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 119 SINGAPORE DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 120 SINGAPORE VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 121 SINGAPORE DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 122 SINGAPORE SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 SINGAPORE DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 124 SINGAPORE DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 125 SINGAPORE DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 126 SINGAPORE HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 SINGAPORE DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 128 MALAYSIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 MALAYSIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 130 MALAYSIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 MALAYSIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 MALAYSIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 133 MALAYSIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 134 MALAYSIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 135 MALAYSIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 136 MALAYSIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 137 MALAYSIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 138 MALAYSIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 139 MALAYSIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 140 MALAYSIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 MALAYSIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 142 MALAYSIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 143 MALAYSIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 144 MALAYSIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 MALAYSIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 146 THAILAND DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 THAILAND TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 148 THAILAND IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 THAILAND SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 THAILAND CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 151 THAILAND ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 152 THAILAND ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 153 THAILAND DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 154 THAILAND OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 155 THAILAND DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 156 THAILAND VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 157 THAILAND DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 158 THAILAND SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 THAILAND DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 160 THAILAND DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 161 THAILAND DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 162 THAILAND HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 THAILAND DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 164 INDONESIA DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 INDONESIA TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 166 INDONESIA IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 INDONESIA SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 INDONESIA CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 169 INDONESIA ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 170 INDONESIA ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 171 INDONESIA DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 172 INDONESIA OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 173 INDONESIA DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 174 INDONESIA VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 175 INDONESIA DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 176 INDONESIA SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 INDONESIA DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 178 INDONESIA DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 179 INDONESIA DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 180 INDONESIA HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 INDONESIA DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 182 VIETNAM DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 VIETNAM TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 184 VIETNAM IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 VIETNAM SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 VIETNAM CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 187 VIETNAM ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 188 VIETNAM ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 189 VIETNAM DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 190 VIETNAM OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 191 VIETNAM DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 192 VIETNAM VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 193 VIETNAM DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 194 VIETNAM SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 VIETNAM DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 196 VIETNAM DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 197 VIETNAM DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 VIETNAM HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 VIETNAM DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 200 PHILIPPINES DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 PHILIPPINES TRADITIONAL PACS IN DEPARTMENTAL PACS MARKET, BY FUNCTIONALITY, 2022-2031 (USD THOUSAND)
TABLE 202 PHILIPPINES IMAGE MANAGEMENT IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 PHILIPPINES SPECIALITY PACS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 PHILIPPINES CARDIOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 205 PHILIPPINES ONCOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 206 PHILIPPINES ORTHOPEDIC PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 207 PHILIPPINES DERMATOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 208 PHILIPPINES OPHTHALMOLOGY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 209 PHILIPPINES DENTAL PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 210 PHILIPPINES VETERINARY PACS IN DEPARTMENTAL PACS MARKET, BY IMAGING MODALITIES, 2022-2031 (USD THOUSAND)
TABLE 211 PHILIPPINES DEPARTMENTAL PACS MARKET, BY COMPONENT, 2022-2031 (USD THOUSAND)
TABLE 212 PHILIPPINES SOFTWARE IN DEPARTMENTAL PACS MARKET, BY DEPLOYMENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 213 PHILIPPINES DEPARTMENTAL PACS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 214 PHILIPPINES DEPARTMENTAL PACS MARKET, BY INTEGRATION LEVEL, 2022-2031 (USD THOUSAND)
TABLE 215 PHILIPPINES DEPARTMENTAL PACS MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 PHILIPPINES HOSPITALS IN DEPARTMENTAL PACS MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 PHILIPPINES DEPARTMENTAL PACS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 218 REST OF ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE, 2022-2031 (USD THOUSAND)
图片列表
FIGURE 1 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: ASIA-PACIFIC VS REGIONS MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SEGMENTATION
FIGURE 11 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET, BY PRODUCT TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISION
FIGURE 14 RISING DEMAND FOR EARLY DISEASE DETECTION IS DRIVING THE GROWTH OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET FROM 2024 TO 2031
FIGURE 15 THE MIXERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC (APAC) DEPARTMENTAL PACS MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2023
FIGURE 18 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2023
FIGURE 22 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, 2024-2031 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2023
FIGURE 26 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2023
FIGURE 30 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, 2024-2031 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY INTEGRATION LEVEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER 2023
FIGURE 34 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET: END USER, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC (APAC) HOSPITALS IN DEPARTMENTAL PACS MARKET END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 38 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 39 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 40 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: SNAPSHOT (2023)
FIGURE 42 ASIA-PACIFIC (APAC) DEPARTMENTAL PACS MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
